A stability-indicating HPLC method for the separation of clarithromycin and related substances in bulk samples
β Scribed by Kennedy O. Abuga; Hezekiah K. Chepkwony; Eugene Roets; Jos Hoogmartens
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 137 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1615-9306
No coin nor oath required. For personal study only.
β¦ Synopsis
A stability-indicating HPLC method for the separation of clarithromycin and related substances in bulk samples Clarithromycin is a 6-O-methylated semi-synthetic derivative of erythromycin A, which is more resistant towards acid decomposition. Commercial clarithromycin samples contain several potential impurities arising from the manufacturing process and degradation. A simple, selective, and sensitive isocratic liquid chromatographic method has been developed for the impurity profiling of clarithromycin bulk samples. The method employs a XTerra RP18, 5 lm, 25064.6 mm column thermostated at 568C. The mobile phase consists of acetonitrile -0.2 M potassium phosphate buffer pH 6.80 -water (40 : 3.5 : 56.5). Several peaks are of unknown identity. The method is stability indicating.
π SIMILAR VOLUMES
## Abstract Two sensitive and reproducible methods were developed and validated for the determination of ziprasidone (ZIP) in the presence of its degradation products in pure form and in pharmaceutical formulations. The ο¬rst method was based on reversedβphase highβperformance liquid chromatography
## Abstract A sensitive and selective LCβMS/MS method was developed and validated for the determination of aconitine in microdialysate and rat plasma. Extraction of plasma sample was conducted by use of 1% trichloracetic acid and acetonitrile solution with 10 ng/mL internal standard (propafenone) s